Retention in HIV care during pregnancy and the postpartum period in the option B+ era: systematic review and meta-analysis of studies in Africa

BA Knettel, C Cichowitz, JS Ngocho… - JAIDS Journal of …, 2018 - journals.lww.com
Background: Under Option B+ guidelines for prevention of mother-to-child transmission of
HIV, pregnant and breastfeeding women initiate antiretroviral therapy for lifelong use. The …

Interventions to significantly improve service uptake and retention of HIV‐positive pregnant women and HIV‐exposed infants along the prevention of mother‐to‐child …

AC Vrazo, J Firth, A Amzel, R Sedillo… - Tropical Medicine & …, 2018 - Wiley Online Library
Objectives Despite the success of Prevention of Mother‐to‐Child Transmission of HIV
(PMTCT) programmes, low uptake of services and poor retention pose a formidable …

No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception

L Mandelbrot, R Tubiana, J Le Chenadec… - Clinical Infectious …, 2015 - academic.oup.com
Background. The efficacy of preventing perinatal transmission (PT) of human
immunodeficiency virus type 1 (HIV-1) depends on both viral load (VL) and treatment …

Same-day HIV testing with initiation of antiretroviral therapy versus standard care for persons living with HIV: a randomized unblinded trial

SP Koenig, N Dorvil, JG Dévieux… - PLoS …, 2017 - journals.plos.org
Background Attrition during the period from HIV testing to antiretroviral therapy (ART)
initiation is high worldwide. We assessed whether same-day HIV testing and ART initiation …

Adherence to antiretroviral therapy during and after pregnancy: cohort study on women receiving care in Malawi's option B+ program

AD Haas, MT Msukwa, M Egger… - Clinical infectious …, 2016 - academic.oup.com
Background. Adherence to antiretroviral therapy (ART) is crucial to preventing mother-to-
child transmission of human immunodeficiency virus (HIV) and ensuring the long-term …

Retention in care during the first 3 years of antiretroviral therapy for women in Malawi's option B+ programme: an observational cohort study

AD Haas, L Tenthani, MT Msukwa, K Tal, A Jahn… - The lancet HIV, 2016 - thelancet.com
Summary Background Studies of Malawi's option B+ programme for HIV-positive pregnant
and breastfeeding women have reported high loss to follow-up during pregnancy and at the …

Association of implementation of a universal testing and treatment intervention with HIV diagnosis, receipt of antiretroviral therapy, and viral suppression in East Africa

M Petersen, L Balzer, D Kwarsiima, N Sang, G Chamie… - Jama, 2017 - jamanetwork.com
Importance Antiretroviral treatment (ART) is now recommended for all HIV-positive persons.
UNAIDS has set global targets to diagnose 90% of HIV-positive individuals, treat 90% of …

Understanding factors, outcomes and reasons for loss to follow‐up among women in O ption B+ PMTCT programme in L ilongwe, M alawi

H Tweya, S Gugsa, M Hosseinipour… - Tropical Medicine & …, 2014 - Wiley Online Library
Objective To assess factors, outcomes and reasons for loss to follow‐up (LTFU) among
pregnant and breastfeeding women initiated on a lifelong antiretroviral therapy (ART) for …

“What they wanted was to give birth; nothing else”: barriers to retention in option B+ HIV care among postpartum women in South Africa

K Clouse, S Schwartz, A Van Rie… - JAIDS Journal of …, 2014 - journals.lww.com
Background: Women initiating antiretroviral therapy during pregnancy have high rates of
dropout, particularly after delivery. We aimed to identify challenges to postpartum retention …

Why did I stop? Barriers and facilitators to uptake and adherence to ART in Option B+ HIV care in Lilongwe, Malawi

MH Kim, A Zhou, A Mazenga, S Ahmed, C Markham… - PloS one, 2016 - journals.plos.org
Causes for loss-to-follow-up, including early refusals of and stopping antiretroviral therapy
(ART), in Malawi's Option B+ program are poorly understood. This study examines the main …